Please name these "more successful peers". You mean the ones with all the debt that are growing capacity as fast as they can which will lead to oversupply conditions in a couple years?
No one is buying what Emblem is selling
Ummm... nobody is buying the adult use brand because it can't be sold until October 17th. That is why they didn't begin their marketing campaign until 100 days out for legal sales. As far as the medical side... of course people are buying. Patient count should be over 4,000 now. Wasn't long ago that they were approved to sell oils ($14/gram vs. $8.50/gram dried flower) and oils were a third of revenue in Q1. This higher margin product should continue to accelerate rapidly.
Will be interesting to hear your commentary after Q2 numbers. Quarter over quarter should be impressive with a clear path to positive earnings by the end of the year.
News 
Market Data 
Discover 
